UA81689C2 - Способ предоперационного лечения послеоперационной боли бупренорфином - Google Patents

Способ предоперационного лечения послеоперационной боли бупренорфином

Info

Publication number
UA81689C2
UA81689C2 UAA200602137A UAA200602137A UA81689C2 UA 81689 C2 UA81689 C2 UA 81689C2 UA A200602137 A UAA200602137 A UA A200602137A UA A200602137 A UAA200602137 A UA A200602137A UA 81689 C2 UA81689 C2 UA 81689C2
Authority
UA
Ukraine
Prior art keywords
buprenorphine
operative pain
post operative
preoperative treatment
surgery
Prior art date
Application number
UAA200602137A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Брюс Э. Райденберг
Дениэл А. Спайкер
Original Assignee
Евро-Селтик С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евро-Селтик С.А. filed Critical Евро-Селтик С.А.
Publication of UA81689C2 publication Critical patent/UA81689C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)
UAA200602137A 2003-07-25 2004-07-26 Способ предоперационного лечения послеоперационной боли бупренорфином UA81689C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
PCT/US2004/024009 WO2005011578A2 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (1)

Publication Number Publication Date
UA81689C2 true UA81689C2 (ru) 2008-01-25

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200602137A UA81689C2 (ru) 2003-07-25 2004-07-26 Способ предоперационного лечения послеоперационной боли бупренорфином

Country Status (27)

Country Link
US (3) US20080026042A1 (enExample)
EP (1) EP1638492B1 (enExample)
JP (1) JP5632573B2 (enExample)
KR (4) KR20080011248A (enExample)
CN (1) CN1829489B (enExample)
AT (1) ATE382354T1 (enExample)
AU (1) AU2004261181B2 (enExample)
BR (1) BRPI0412924A (enExample)
CA (1) CA2529983C (enExample)
CY (1) CY1107352T1 (enExample)
DE (1) DE602004011055T2 (enExample)
DK (1) DK1638492T3 (enExample)
EA (1) EA009213B1 (enExample)
ES (1) ES2299871T3 (enExample)
GE (1) GEP201606538B (enExample)
HR (1) HRP20080146T3 (enExample)
IL (1) IL173345A (enExample)
IS (1) IS8186A (enExample)
MA (1) MA28005A1 (enExample)
MX (1) MXPA06000990A (enExample)
NO (1) NO326636B1 (enExample)
NZ (1) NZ594154A (enExample)
PL (1) PL1638492T3 (enExample)
PT (1) PT1638492E (enExample)
UA (1) UA81689C2 (enExample)
WO (1) WO2005011578A2 (enExample)
ZA (1) ZA200510071B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
ES2688577T3 (es) 2010-09-03 2018-11-05 Zoetis Belgium S.A. Composiciones de buprenorfina en dosis altas y uso como analgésico
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (en) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
DK0484543T3 (da) * 1990-04-24 1996-01-22 Teijin Ltd Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
DK2113315T3 (da) * 2001-04-23 2014-08-18 Euro Celtique Sa Bortskaffelsessystem til transdermal doseringsform
PT2062573E (pt) * 2001-05-01 2012-01-11 Euro Celtique Sa Sistemas transdérmicos que contêm opióides que resistem a violação
DE60235159D1 (de) * 2001-05-22 2010-03-11 Euro Celtique Sa Behälter und verfahren zum abgeben transdermaler dosierungsformen
MXPA05006334A (es) * 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией

Also Published As

Publication number Publication date
IS8186A (is) 2005-12-19
EP1638492B1 (en) 2008-01-02
EP1638492A2 (en) 2006-03-29
KR20120128715A (ko) 2012-11-27
HRP20080146T3 (en) 2008-04-30
CA2529983A1 (en) 2005-02-10
EA200600284A1 (ru) 2006-06-30
KR20080011248A (ko) 2008-01-31
CN1829489A (zh) 2006-09-06
MXPA06000990A (es) 2006-04-11
IL173345A0 (en) 2006-06-11
MA28005A1 (fr) 2006-07-03
GEP201606538B (en) 2016-09-12
JP5632573B2 (ja) 2014-11-26
ATE382354T1 (de) 2008-01-15
DE602004011055T2 (de) 2008-12-18
EP1638492A4 (en) 2006-07-19
AU2004261181B2 (en) 2009-08-06
KR20090031961A (ko) 2009-03-30
KR20060054346A (ko) 2006-05-22
CY1107352T1 (el) 2012-12-19
PT1638492E (pt) 2008-03-17
CN1829489B (zh) 2010-12-15
US20110002975A1 (en) 2011-01-06
HK1087907A1 (en) 2006-10-27
BRPI0412924A (pt) 2006-09-26
US20140221413A1 (en) 2014-08-07
WO2005011578A3 (en) 2005-09-09
NZ594154A (en) 2012-12-21
DE602004011055D1 (de) 2008-02-14
NO326636B1 (no) 2009-01-26
ZA200510071B (en) 2006-11-29
PL1638492T3 (pl) 2008-06-30
AU2004261181A1 (en) 2005-02-10
DK1638492T3 (da) 2008-05-13
EA009213B1 (ru) 2007-12-28
WO2005011578A2 (en) 2005-02-10
JP2007500133A (ja) 2007-01-11
ES2299871T3 (es) 2008-06-01
NO20060912L (no) 2006-04-21
CA2529983C (en) 2010-07-20
IL173345A (en) 2010-06-16
US20080026042A1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
DE69823520D1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
CY1107262T1 (el) Θεραπεια της εξαρτησης στερησης
DE60320770D1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
MX2024011142A (es) Tratamiento de neurofibromas cutaneos con mirdametinib.
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
GB0405381D0 (en) A method and means for treating heart failure
WO2008088987B1 (en) Treatment of pain with naloxone
RU2004106092A (ru) Способ лечения открытого перелома конечности